Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

The risks of testosterone implants in women outweigh the benefits.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

The document suggests that finasteride may cause depression and suicidal thoughts, while prostate surgery does not harm sexual health.

Hoyeraal-Hreidarsson syndrome in infants causes severe gastrointestinal issues.

Pilonidal sinus disease is linked to more severe hidradenitis suppurativa.

A deletion in the CDH3 gene causes a rare disorder with short hair and vision loss.

People with certain skin disorders are more likely to have alcohol problems, especially if they also have mental health issues like depression and anxiety.

HLD10 can include increased body hair and Mongolian spots.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

A rare genetic disorder causes sparse hair and vision loss due to a CDH3 gene mutation.

A woman was diagnosed with Sheehan's syndrome and a rare complication of diabetes insipidus 33 years after symptoms began, improving with hormone therapy.

A new mutation in the CDH3 gene causes hair loss and vision problems in a young girl.

Patients with Shwachman-Diamond syndrome often get misdiagnosed due to a wide range of symptoms, including immune system problems and bone abnormalities.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

A genetic mutation in a specific gene causes a salt-wasting condition in a Pakistani girl and her family.

A rare gene variant causes sexual development issues in siblings, needing personalized treatment.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

A rare genetic disease causes sparse hair and early blindness due to a gene mutation.